80 related articles for article (PubMed ID: 17594508)
1. Structural and enzymatic insights into caspase-2 protein substrate recognition and catalysis.
Tang Y; Wells JA; Arkin MR
J Biol Chem; 2011 Sep; 286(39):34147-54. PubMed ID: 21828056
[TBL] [Abstract][Full Text] [Related]
2. Phage display and structural studies reveal plasticity in substrate specificity of caspase-3a from zebrafish.
Tucker MB; MacKenzie SH; Maciag JJ; Dirscherl Ackerman H; Swartz P; Yoder JA; Hamilton PT; Clay Clark A
Protein Sci; 2016 Nov; 25(11):2076-2088. PubMed ID: 27577093
[TBL] [Abstract][Full Text] [Related]
3. Engaging a Non-catalytic Cysteine Residue Drives Potent and Selective Inhibition of Caspase-6.
Van Horn KS; Wang D; Medina-Cleghorn D; Lee PS; Bryant C; Altobelli C; Jaishankar P; Leung KK; Ng RA; Ambrose AJ; Tang Y; Arkin MR; Renslo AR
J Am Chem Soc; 2023 May; 145(18):10015-10021. PubMed ID: 37104712
[TBL] [Abstract][Full Text] [Related]
4. In silico identification and crystal structure validation of caspase-3 inhibitors without a P1 aspartic acid moiety.
Ganesan R; Jelakovic S; Mittl PR; Caflisch A; Grütter MG
Acta Crystallogr Sect F Struct Biol Cryst Commun; 2011 Aug; 67(Pt 8):842-50. PubMed ID: 21821879
[TBL] [Abstract][Full Text] [Related]
5. A highly potent and selective caspase 1 inhibitor that utilizes a key 3-cyanopropanoic acid moiety.
Boxer MB; Quinn AM; Shen M; Jadhav A; Leister W; Simeonov A; Auld DS; Thomas CJ
ChemMedChem; 2010 May; 5(5):730-8. PubMed ID: 20229566
[TBL] [Abstract][Full Text] [Related]
6. Downregulation of SF3B2 protects CNS neurons in models of multiple sclerosis.
Jeong YE; Rajbhandari L; Kim BW; Venkatesan A; Hoke A
Ann Clin Transl Neurol; 2023 Feb; 10(2):246-265. PubMed ID: 36574260
[TBL] [Abstract][Full Text] [Related]
7. Regulation of pyroptosis in cardiovascular pathologies: Role of noncoding RNAs.
Gao J; Chen X; Wei P; Wang Y; Li P; Shao K
Mol Ther Nucleic Acids; 2021 Sep; 25():220-236. PubMed ID: 34458007
[TBL] [Abstract][Full Text] [Related]
8. Low levels of Caspase-3 predict favourable response to 5FU-based chemotherapy in advanced colorectal cancer: Caspase-3 inhibition as a therapeutic approach.
Flanagan L; Meyer M; Fay J; Curry S; Bacon O; Duessmann H; John K; Boland KC; McNamara DA; Kay EW; Bantel H; Schulze-Bergkamen H; Prehn JH
Cell Death Dis; 2016 Feb; 7(2):e2087. PubMed ID: 26844701
[TBL] [Abstract][Full Text] [Related]
9. Small Molecule Active Site Directed Tools for Studying Human Caspases.
Poreba M; Szalek A; Kasperkiewicz P; Rut W; Salvesen GS; Drag M
Chem Rev; 2015 Nov; 115(22):12546-629. PubMed ID: 26551511
[TBL] [Abstract][Full Text] [Related]
10. Novel Death Defying Domain in Met entraps the active site of caspase-3 and blocks apoptosis in hepatocytes.
Ma J; Zou C; Guo L; Seneviratne DS; Tan X; Kwon YK; An J; Bowser R; DeFrances MC; Zarnegar R
Hepatology; 2014 May; 59(5):2010-21. PubMed ID: 24122846
[TBL] [Abstract][Full Text] [Related]
11. Specificity of a protein-protein interface: local dynamics direct substrate recognition of effector caspases.
Fuchs JE; von Grafenstein S; Huber RG; Wallnoefer HG; Liedl KR
Proteins; 2014 Apr; 82(4):546-55. PubMed ID: 24085488
[TBL] [Abstract][Full Text] [Related]
12. Altered apoptotic responses in neurons lacking RhoB GTPase.
Barberan S; McNair K; Iqbal K; Smith NC; Prendergast GC; Stone TW; Cobb SR; Morris BJ
Eur J Neurosci; 2011 Dec; 34(11):1737-46. PubMed ID: 22098422
[TBL] [Abstract][Full Text] [Related]
13. α-Mangostin extracted from the pericarp of the mangosteen (Garcinia mangostana Linn) reduces tumor growth and lymph node metastasis in an immunocompetent xenograft model of metastatic mammary cancer carrying a p53 mutation.
Shibata MA; Iinuma M; Morimoto J; Kurose H; Akamatsu K; Okuno Y; Akao Y; Otsuki Y
BMC Med; 2011 Jun; 9():69. PubMed ID: 21639868
[TBL] [Abstract][Full Text] [Related]
14. Raloxifene inhibits tumor growth and lymph node metastasis in a xenograft model of metastatic mammary cancer.
Shibata MA; Morimoto J; Shibata E; Kurose H; Akamatsu K; Li ZL; Kusakabe M; Ohmichi M; Otsuki Y
BMC Cancer; 2010 Oct; 10():566. PubMed ID: 20958960
[TBL] [Abstract][Full Text] [Related]
15. Structural and functional definition of the specificity of a novel caspase-3 inhibitor, Ac-DNLD-CHO.
Yoshimori A; Sakai J; Sunaga S; Kobayashi T; Takahashi S; Okita N; Takasawa R; Tanuma S
BMC Pharmacol; 2007 Jun; 7():8. PubMed ID: 17594508
[TBL] [Abstract][Full Text] [Related]
16. A novel method for evaluation and screening of caspase inhibitory peptides by the amino acid positional fitness score.
Yoshimori A; Takasawa R; Tanuma S
BMC Pharmacol; 2004 May; 4():7. PubMed ID: 15154972
[TBL] [Abstract][Full Text] [Related]
17. Plasticity of S2-S4 specificity pockets of executioner caspase-7 revealed by structural and kinetic analysis.
Agniswamy J; Fang B; Weber IT
FEBS J; 2007 Sep; 274(18):4752-65. PubMed ID: 17697120
[TBL] [Abstract][Full Text] [Related]
18. Structure-based discovery of a novel non-peptidic small molecular inhibitor of caspase-3.
Sakai J; Yoshimori A; Nose Y; Mizoroki A; Okita N; Takasawa R; Tanuma S
Bioorg Med Chem; 2008 May; 16(9):4854-9. PubMed ID: 18387304
[TBL] [Abstract][Full Text] [Related]
19. Caspase inhibitors: a review of recently patented compounds (2013-2015).
Lee H; Shin EA; Lee JH; Ahn D; Kim CG; Kim JH; Kim SH
Expert Opin Ther Pat; 2018 Jan; 28(1):47-59. PubMed ID: 28885866
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
